Cargando…

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

PURPOSE: The association between exposure to testosterone replacement therapy (TRT) and prostate cancer risk is controversial. The objective was to examine this association through nationwide, population-based registry data. METHODS: We performed a nested case-control study in the National Prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loeb, Stacy, Folkvaljon, Yasin, Damber, Jan-Erik, Alukal, Joseph, Lambe, Mats, Stattin, Pär
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2017
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455459/ https://www.ncbi.nlm.nih.gov/pubmed/28447913 http://dx.doi.org/10.1200/JCO.2016.69.5304

Ejemplares similares

Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma
por: Loeb, Stacy, et al.
Publicado: (2017)

Prostate Cancer Imaging Trends After a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging
por: Makarov, Danil V., et al.
Publicado: (2013)

Public online reporting from a nationwide population‐based clinical prostate cancer register
por: Stattin, Pär, et al.
Publicado: (2018)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic
por: Gedeborg, Rolf, et al.
Publicado: (2021)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Susceptibility to SARS‐Cov‐2 infection and risk for severe COVID‐19 in patients with prostate cancer on androgen deprivation therapy
por: Gedeborg, Rolf, et al.
Publicado: (2022)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Long‐term adverse effects after retropubic and robot‐assisted radical prostatectomy. Nationwide, population‐based study
por: Fridriksson, Jón Örn, et al.
Publicado: (2017)

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study
por: Tomic, Katarina, et al.
Publicado: (2018)

Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study
por: Plym, Anna, et al.
Publicado: (2020)

Testosterone Replacement Therapy and Prostate Cancer Incidence
por: Eisenberg, Michael Louis
Publicado: (2015)

Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
por: Van Hemelrijck, Mieke, et al.
Publicado: (2010)

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
por: Bell, Michael A., et al.
Publicado: (2018)

Nationwide, population‐based study of post radical prostatectomy urinary incontinence correction surgery
por: Ventimiglia, Eugenio, et al.
Publicado: (2017)

Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer.
por: Stattin, P., et al.
Publicado: (1998)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
por: Atan, Ali, et al.
Publicado: (2013)

Testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016)

Testosterone Replacement Therapy
por: Hellstrom, Wayne J.G.
Publicado: (2004)

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
por: Walsh, Thomas J., et al.
Publicado: (2018)

The effects of testosterone replacement therapy on the prostate: a clinical perspective
por: Miah, Saiful, et al.
Publicado: (2019)

Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study
por: Shore, Richard, et al.
Publicado: (2023)

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
por: Parker, Jonathan, et al.
Publicado: (2020)

Population‐based study of long‐term functional outcomes after prostate cancer treatment
por: Carlsson, Sigrid, et al.
Publicado: (2015)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Is Oral Testosterone the New Frontier of Testosterone Replacement Therapy?
por: Ahmad, Syed W, et al.
Publicado: (2022)

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
por: Stattin, Pär, et al.
Publicado: (2010)

Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study
por: Fridriksson, Jón Ö., et al.
Publicado: (2016)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
por: Kim, Jin Wook
Publicado: (2020)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

Testosterone replacement therapy for older men
por: Borst, Stephen E, et al.
Publicado: (2007)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Transdermal testosterone replacement therapy in men
por: Ullah, M Iftekhar, et al.
Publicado: (2014)

Testosterone replacement therapy and voiding dysfunction
por: Baas, Wesley, et al.
Publicado: (2016)

Off label therapies for testosterone replacement
por: DiGiorgio, Lorenzo, et al.
Publicado: (2016)

Pharmacology of testosterone replacement therapy preparations
por: Shoskes, Jennifer J., et al.
Publicado: (2016)

Evolution of Guidelines for Testosterone Replacement Therapy
por: Park, Hyun Jun, et al.
Publicado: (2019)

Testosterone Replacement Therapy and the Risk of Hypoglycemia
por: Yamaguchi, Analía Verónica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_atjer900am03p2ha6626j621a5